These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 22630153

  • 1. Nanoprobes for hybrid SPECT/MR molecular imaging.
    Misri R, Saatchi K, Häfeli UO.
    Nanomedicine (Lond); 2012 May; 7(5):719-33. PubMed ID: 22630153
    [Abstract] [Full Text] [Related]

  • 2. Radiolabeled iron oxide nanoparticles as dual-modality SPECT/MRI and PET/MRI agents.
    Bouziotis P, Psimadas D, Tsotakos T, Stamopoulos D, Tsoukalas C.
    Curr Top Med Chem; 2012 May; 12(23):2694-702. PubMed ID: 23339765
    [Abstract] [Full Text] [Related]

  • 3. Recent advances in hybrid molecular imaging systems.
    Lee JS, Kim JH.
    Semin Musculoskelet Radiol; 2014 Apr; 18(2):103-22. PubMed ID: 24715444
    [Abstract] [Full Text] [Related]

  • 4. Developments of magnetic resonance imaging and spectroscopy in the field of molecular imaging.
    Aime S, Bisi G.
    Q J Nucl Med Mol Imaging; 2009 Dec; 53(6):563-4. PubMed ID: 20016449
    [No Abstract] [Full Text] [Related]

  • 5. Synthesis of heterodimer radionuclide nanoparticles for magnetic resonance and single-photon emission computed tomography dual-modality imaging.
    Zhu J, Zhang B, Tian J, Wang J, Chong Y, Wang X, Deng Y, Tang M, Li Y, Ge C, Pan Y, Gu H.
    Nanoscale; 2015 Feb 28; 7(8):3392-5. PubMed ID: 25584713
    [Abstract] [Full Text] [Related]

  • 6. A comparison of MR-based attenuation correction in PET versus SPECT.
    Marshall HR, Stodilka RZ, Theberge J, Sabondjian E, Legros A, Deans L, Sykes JM, Thompson RT, Prato FS.
    Phys Med Biol; 2011 Jul 21; 56(14):4613-29. PubMed ID: 21725141
    [Abstract] [Full Text] [Related]

  • 7. Development and evaluation of a dual-modality (MRI/SPECT) molecular imaging bioprobe.
    Misri R, Meier D, Yung AC, Kozlowski P, Häfeli UO.
    Nanomedicine; 2012 Aug 21; 8(6):1007-16. PubMed ID: 22100757
    [Abstract] [Full Text] [Related]

  • 8. PET-MR and SPECT-MR multimodality probes: Development and challenges.
    Yang CT, Ghosh KK, Padmanabhan P, Langer O, Liu J, Eng DNC, Halldin C, Gulyás B.
    Theranostics; 2018 Aug 21; 8(22):6210-6232. PubMed ID: 30613293
    [Abstract] [Full Text] [Related]

  • 9. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH, von Gall C, Zeilinger M, Wiesmüller M, Braun H, Ziegler S, Kuwert T, Uder M, Dörfler A, Kalender WA, Lell M.
    Invest Radiol; 2013 May 21; 48(5):280-9. PubMed ID: 23442775
    [Abstract] [Full Text] [Related]

  • 10. Bioengineered Magnetoferritin Nanoprobes for Single-Dose Nuclear-Magnetic Resonance Tumor Imaging.
    Zhao Y, Liang M, Li X, Fan K, Xiao J, Li Y, Shi H, Wang F, Choi HS, Cheng D, Yan X.
    ACS Nano; 2016 Apr 26; 10(4):4184-91. PubMed ID: 26959856
    [Abstract] [Full Text] [Related]

  • 11. Tunable and noncytotoxic PET/SPECT-MRI multimodality imaging probes using colloidally stable ligand-free superparamagnetic iron oxide nanoparticles.
    Pham TN, Lengkeek NA, Greguric I, Kim BJ, Pellegrini PA, Bickley SA, Tanudji MR, Jones SK, Hawkett BS, Pham BT.
    Int J Nanomedicine; 2017 Apr 26; 12():899-909. PubMed ID: 28184160
    [Abstract] [Full Text] [Related]

  • 12. Integrity of (111)In-radiolabeled superparamagnetic iron oxide nanoparticles in the mouse.
    Wang H, Kumar R, Nagesha D, Duclos RI, Sridhar S, Gatley SJ.
    Nucl Med Biol; 2015 Jan 26; 42(1):65-70. PubMed ID: 25277378
    [Abstract] [Full Text] [Related]

  • 13. Nanoparticles for molecular imaging--an overview.
    Minchin RF, Martin DJ.
    Endocrinology; 2010 Feb 26; 151(2):474-81. PubMed ID: 20016027
    [Abstract] [Full Text] [Related]

  • 14. Rationale for the combination of nuclear medicine with magnetic resonance for pre-clinical imaging.
    Wagenaar DJ, Kapusta M, Li J, Patt BE.
    Technol Cancer Res Treat; 2006 Aug 26; 5(4):343-50. PubMed ID: 16866565
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors.
    Gaertner FC, Beer AJ, Souvatzoglou M, Eiber M, Fürst S, Ziegler SI, Brohl F, Schwaiger M, Scheidhauer K.
    Invest Radiol; 2013 May 26; 48(5):263-72. PubMed ID: 23385399
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction.
    Ibrahim T, Bülow HP, Hackl T, Hörnke M, Nekolla SG, Breuer M, Schömig A, Schwaiger M.
    J Am Coll Cardiol; 2007 Jan 16; 49(2):208-16. PubMed ID: 17222732
    [Abstract] [Full Text] [Related]

  • 17. Hybrid PET/MR imaging of tumors using an oleanolic acid-conjugated nanoparticle.
    Kim SM, Chae MK, Yim MS, Jeong IH, Cho J, Lee C, Ryu EK.
    Biomaterials; 2013 Nov 16; 34(33):8114-21. PubMed ID: 23932293
    [Abstract] [Full Text] [Related]

  • 18. A Radio-Nano-Platform for T1/T2 Dual-Mode PET-MR Imaging.
    Gholami YH, Yuan H, Wilks MQ, Maschmeyer R, Normandin MD, Josephson L, El Fakhri G, Kuncic Z.
    Int J Nanomedicine; 2020 Nov 16; 15():1253-1266. PubMed ID: 32161456
    [Abstract] [Full Text] [Related]

  • 19. Liver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)-enhanced MR imaging, computed tomography and positron emission tomography.
    Rappeport ED, Loft A.
    Abdom Imaging; 2007 Nov 16; 32(5):624-34. PubMed ID: 17710359
    [Abstract] [Full Text] [Related]

  • 20. [Clinical applications of molecular imaging methods for patients with ischemic stroke].
    Yamauchi H, Fukuyama H.
    Nihon Rinsho; 2007 Feb 16; 65(2):315-9. PubMed ID: 17302277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.